Clinical Trial Resource Center
Welcome to the National Pancreas Foundation Clinical Trials Resource Center, presented in partnership with CenterWatch, the leading publisher of information on clinical research for patients, their advocates and healthcare professionals. Please click on the links below to learn more about clinical research and about new medical therapies for treating pancreas disease and related indications.
This section provides background information about the clinical trials process and what to expect when you volunteer to participate in a clinical trial. Here, you’ll find answers to frequently asked questions about clinical trials and also suggestions for where to find more information.
Listing of Clinical Trials
TITLE: Chronic Pancreatitis Trial – Kangen Pharmaceuticals. A Phase 2, randomized, DOUBLE-BLIND, PARALLEL‑GROUP dose-ranging STUDY TO EVALUATE THE Safety and efficacy OF Ni-03 compared to placebo in subjects with chronic pancreatitis.
A multicenter, randomized, double-blind, placebo controlled study of three doses of NI-03. The aim of the study is to evaluate if the study drug is effective in treating the acute symptoms of chronic pancreatitis when given for 4 weeks. The study is currently enrolling patients nationwide.
If you or someone you love is 18 years of age or older and diagnosed with Chronic Pancreatitis, you may qualify for a clinical trial. Please CLICK HERE to visit the TACTIC study website to answer a few simple questions about your Chronic Pancreatitis and locate a site nearest you. Eligible participants will receive study-related treatment at no charge, and will also receive compensation for their time and travel.
TITLE: Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
This research study—called the DETECT* Study – is funded by the National Institutes of Health (NIH) and is seeking to develop a blood test that can separate diabetes caused by pancreatic cancer or chronic pancreatitis from type 2 diabetes.
The study includes participants from 8 research centers in the United States. If you have pancreatic cancer or chronic pancreatitis, and have also been diagnosed with diabetes and are 40 to 85 years old, you may be eligible after review of other factors. For more information, please CLICK HERE
TITLE: ISIS 304801-CS7 The APPROACH Open Label Study Volanesorsen (ISIS 304801) An Open-Label Study of Volanesorsen Administered Subcutaneously to Patients With Familial Chylomicronemia Syndrome (FCS) (Phase III Clinical Trial for Familial Chylomicronemia Syndrome (FCS)
This is a multi-center, open-label study. All patients will receive volanesorsen 300 mg once per week for 52 weeks. Patients will have the option of continuing dosing for an additional 52 weeks until an expanded access program is approved and available in their country. For more information, please CLICK HERE.
TITLE: SpHincterotomy for Acute Recurrent Pancreatitis (SHARP)
This NIH-sponsored Randomized Clinical Trial is currently enrolling subjects to learn whether an Endoscopic Retrograde CholangioPancreatography (ERCP) with sphincterotomy is beneficial in patients with acute recurrent pancreatitis and pancreas divisum.
The purpose of this study is to determine if a ERCP with sphincterotomy reduces the risk of pancreatitis or the number of recurrent pancreatitis episodes in patients with pancreas divisum. ERCP with sphincterotomy is a procedure where doctors used a combination of x-rays and an endoscope (a long flexible lighted tube) to find the opening of the duct where fluid drains out of the pancreas. People who have been diagnosed with pancreas divisum, have had at least two episodes of pancreatitis, and are candidates for the ERCP with sphincterotomy procedure may be eligible to participate. Participants will be will be randomly assigned to either have the ERCP with sphincterotomy procedure, or to have a “sham” procedure. Participants will have follow up visits 30 days after the procedure, 6 months after the procedure, and continuing every 6 months until a maximum follow-up period of 48 months.
For more information please go here: https://www.sharpdivisumtrial.com/
There are currently several sites ready to enroll patients across the nation. For more information about the study and contact on sites is available here: https://clinicaltrials.gov/ct2/show/study/NCT03609944
If you are interested participating, please call (843) 876-4261
Title: WEBMAP CP STUDY
This research study is for children with pain from chronic pancreatitis
Researchers at Seattle Children’s Hospital want to learn more about pain management strategies to help youth with pancreatitis! Children ages 10-18 and their parents can earn up to $300 for their time. Study participation is completely online.
Go to https://bit.ly/2sJKFvW to learn more!
Teens who participate in this study will:
• Answer questions about your pain,
mood, sleep, and everyday life at 3
times over 9 months.
• Use a website for 8-12 weeks, to
learn pain coping skills, which might
help with managing pain
To participate in this study or learn more, please fill out the form located at https://is.gd/webmapcpcommunity. If you or a family member have questions about the study, please contact Seattle Children’s staff at 1-855-932-6272 (toll-free) or firstname.lastname@example.org.
Please see below for more details on:
This listing includes government-funded clinical research studies being conducted by the various National Institutes of Health.
Register your email address to be notified when new pancreas disease trials are posted to the database.
This is a comprehensive listing of drugs that have recently been approved by the Food and Drug Administration. The drugs are organized by therapeutic area.
This directory provides detailed profiles of hundreds of clinical research centers organized geographically by state, city, and center name.
Here you’ll find links to news articles and reports on recent advances in clinical research. This section is updated weekly and the information has been published in CenterWatch publications during the past weeks. There may not always be gastroenterology-related material included.
NMT Weekly Trial Results database is provides easy access to information about the results of recently completed and ongoing clinical trials. It is based on published materials from conferences, journals, and company reports. The trial results summaries typically include the name and phase of the drug, the company sponsoring the research, and information on how well the drug has performed.
Contains a variety of reports, brochures, and publications that patients and their advocates can use to learn more about the clinical trials industry and how to identify and volunteer for clinical trials.